FDA revokes emergency use authorization of hydroxychloroquine for COVID-19
Monday, June 15, 2020 - 13:10
in Health & Medicine
The U.S. Food and Drug Administration on Monday revoked the emergency use authorization for malaria drug hydroxychloroquine as a treatment for COVID-19, the use of which has been championed by U.S. President Donald Trump.